…striving for ever-higher earnings, drug companies large and small are relentlessly increasing pricing on old and new drugs because they can. They can because the industry successfully deployed lobbyists who persuaded a receptive Congress to heavily favor their interests, spinning laws away from regulatory controls and toward payment at any price. These circumstances, nurtured by pharma itself, make a 55-fold price increase possible and legal, if outrageous. And that’s the elephant in the room.
Brian Klepper Posted 2/1/13 on The Health Affairs Blog On January 7, a federal appeals court rejected six Georgia primary care physicians’
Patricia Salber First posted 7/14/11 on The Doctor Weighs In Eric Topol, MD wrote an interesting commentary in the July
Brian Klepper Every now and then, a well-intentioned administration does something relatively harmless but so hare-brained and openly foolish that
Jane Sarasohn-Kahn First published 6/24/11 on Health Populi “With the aging of the population and growing health care costs, the
Paul M. Fischer First published on 6/15/11 on MedPage Today A few weeks ago, the Board of the American Academy
by Patricia Salber First published 6/14/11 on The Doctor Weighs In With all of the hullabaloo about health reform, the